Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR51G2 Inhibitors

The olfactory receptor OR51G2 is part of a larger family of genes involved in the complex mechanisms of smell perception. OR51G2, like other olfactory receptors, is encoded by a specific gene that is responsible for the production of a protein which binds to odor molecules and initiates a signal transduction pathway, leading to the perception of smell. The expression of this receptor protein is regulated at the genetic level, and several factors can influence this expression. Research into the modulation of gene expression has identified a variety of chemicals that can downregulate the expression of specific genes. These chemicals often function by interacting with the DNA itself or with the enzymes and other proteins that control the transcriptional machinery. Chemical compounds such as 5-Azacytidine and Decitabine are known to inhibit DNA methyltransferases, potentially leading to the demethylation of gene promoter regions and a consequent decrease in gene expression. Histone deacetylase inhibitors, including Trichostatin A and Valproic Acid, can affect chromatin structure and histone modifications, leading to a repressive state that hinders the transcription of certain genes, such as OR51G2. Other chemicals, such as Mithramycin A and Dactinomycin, are capable of binding to DNA and can block the binding of transcriptionOR51G2 is an olfactory receptor that plays a pivotal role in the detection of odorant molecules, contributing to the sense of smell. The expression of this gene is subject to the intricate regulation of various biochemical pathways within the olfactory sensory neurons. The synthesis of the OR51G2 protein, like that of other olfactory receptors, is finely tuned by a series of transcriptional and epigenetic mechanisms that ensure the precise response to olfactory stimuli. Understanding the regulation of OR51G2 expression is not only fundamental to comprehending olfactory function but can also shed light on the broader context of gene expression control mechanisms in sensory neurons.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound could lead to hypomethylation of the OR51G2 gene by direct inhibition of DNA methyltransferases, resulting in transcriptional repression of OR51G2.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

By selectively binding to DNA sequences rich in guanine and cytosine, Mithramycin A might block transcription factor access to the OR51G2 promoter, thereby silencing this gene′s expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A may prevent the deacetylation of histones associated with the OR51G2 gene, leading to condensed chromatin and consequent transcriptional silencing of OR51G2.

Valproic Acid

99-66-1sc-213144
10 g
$85.00
9
(1)

Valproic Acid, a histone deacetylase inhibitor, could induce hyperacetylation of histones at the OR51G2 locus, which may repress transcriptional initiation of this gene.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

By intercalating into DNA, Actinomycin D could obstruct the advancement of RNA polymerase along the OR51G2 gene, leading to a cessation of OR51G2 mRNA production.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

RG 108 may prevent the methylation of cytosine-phosphate-guanine (CpG) islands near the OR51G2 promoter, causing a decrease in the transcriptional activity of this gene.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

By incorporating into DNA and inhibiting methyltransferases, 5-Aza-2′-Deoxycytidine (Decitabine) might lead to reduced methylation levels at the OR51G2 promoter, causing a decrease in gene expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin (Sirolimus) could disrupt the mTOR signaling pathway, which is crucial for protein synthesis; this disruption might lead to a decrease in OR51G2 protein levels.

Chetomin

1403-36-7sc-202535
sc-202535A
1 mg
5 mg
$182.00
$661.00
10
(1)

Chetomin impedes the formation of the transcriptional complex at hypoxia-responsive elements, which could result in the downregulation of OR51G2 if it is under such control.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Suberoylanilide Hydroxamic Acid (Vorinostat) could alter the expression of OR51G2 by causing an accumulation of acetylated histones, leading to a compact chromatin structure and transcriptional repression of the gene.